{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:07:45Z","timestamp":1761948465781,"version":"build-2065373602"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T00:00:00Z","timestamp":1184112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> To investigate the neuroprotective effects of topically applied brimonidine tartrate 0.2% (BMD), an \u03b1<jats:sub>2<\/jats:sub>\u2010receptor agonist, on the retinal ganglion cell (RGC) layer and inner nuclear layer (INL) of rabbit retina in endothelin\u20101 (ET\u20101)\u2010induced optic nerve (ON) ischaemia model.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Osmotic minipumps were surgically implanted into one eye of 16 New Zealand Albino rabbits to deliver ET\u20101 at the constant rate of 0.5\u2003\u03bcL\/h for 2\u2003weeks. Eyes were divided into four groups. ET\u20101 was given with (Group 3) and without topical BMD therapy (Group 1). Groups 2 and 4 were taken as controls. Rabbits were sacrificed at day 14. Morphological alterations, total cell number and proportion of cells undergoing apoptosis in INL and RGC layer were assessed by histopathological analysis to determine the survival of the cells of the INL and RGC layer.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Endothelin\u20101 led to severe reduction of cells in both the RGC layer and INL in Group 1 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). In Group 3, the total cell number and the proportion of cells undergoing apoptosis in the RGC layer were comparable with the control group (Group 4), whereas the former was found to be higher and the latter was found to be lower than those recorded for Group 1. However, the total cell number in the INL was found to be lower in Group 3 compared with that of Group 4, despite topical BMD therapy (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Topically applied BMD seems to be neuroprotective and antiapoptotic in the ET\u20101\u2010induced ON ischaemia model, especially for RGCs. BMD might be used as an adjuvant agent for its neuroprotective effects in hypoxic\u2010ischaemic conditions such as diabetic retinopathy, normotensive glaucoma and other retinal vascular occlusive conditions which require further investigations.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2007.01533.x","type":"journal-article","created":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T19:36:55Z","timestamp":1184182615000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin\u20101\u2010induced optic nerve ischaemia model"],"prefix":"10.1111","volume":"35","author":[{"given":"Zeynep","family":"Akta\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6khan","family":"G\u00fcrelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan","family":"Aky\u00fcrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merih","family":"\u00d6nol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berati","family":"Hasanreiso\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(89)90221-3"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(02)00008-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)75424-8"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(94)90157-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1995.tb02008.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.57.12.0010"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00132580-200105000-00008"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200206000-00016"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1997.tb00448.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(05)80073-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00068-5"},{"key":"e_1_2_6_13_2","first-page":"1860","article-title":"An endothelin\u20101 induced model of optic nerve ischemia in the rabbit","volume":"37","author":"Orgul S","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033795"},{"key":"e_1_2_6_15_2","first-page":"65","article-title":"Alpha\u20102\u2010adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration","volume":"40","author":"Yoles E","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_16_2","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser induced chronic ocular hypertension","volume":"42","author":"Woldemussie E","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00205-3"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-19-05986.1996"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(94)90054-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713689508995821"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-215-44110"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200206000-00016"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210501500210"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2002.16.1.1"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713680490904386"},{"key":"e_1_2_6_26_2","first-page":"2704","article-title":"Human optic nerve head astrocytes as a target for endothelin\u20101","volume":"43","author":"Prasanna G","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_27_2","first-page":"3223","article-title":"Effects of ET\u20101 on components of anterograde axonal transport in optic nerve","volume":"43","author":"Stokely ME","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_28_2","first-page":"1390","article-title":"Induction of apoptosis in cultured human retina pigment epithelial cells is counteracted by flupirtine","volume":"38","author":"Osborne NN","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1995.11.253"},{"key":"e_1_2_6_30_2","first-page":"708","article-title":"Comperative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits","volume":"23","author":"Achheampong AA","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00206-5"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.4.421"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/112067219900901S09","article-title":"From the lab to the clinic: activation of an \u03b12\u2010agonist pathway is neuroprotective in models of retinal and optic nerve injury","volume":"9","author":"Wheeler LA","year":"1999","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004410000203"},{"key":"e_1_2_6_35_2","first-page":"273","article-title":"Staining apoptosis in paraffin sections. Advantages and limits","volume":"21","author":"Mangili F","year":"1999","journal-title":"Anal Quant Cytol Histol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02891.x"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2007.01533.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2007.01533.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:43:34Z","timestamp":1696920214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2007.01533.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1442-9071.2007.01533.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2007.01533.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"type":"print","value":"1442-6404"},{"type":"electronic","value":"1442-9071"}],"subject":[],"published":{"date-parts":[[2007,7,11]]},"assertion":[{"value":"2007-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}